The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy

• DOI: 10.1016/j.omton.2024.200785
• Publication Date: 2024-02-29T07:17:24Z
• Authors: Anup S. Pathania; Haritha Chava; Ramesh Balusu; Anil K. Pasupulati; Don W. Coulter; Kishore B. Challa...
• Keywords: long non-coding RNAs; non-coding RNAs; cancer; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; Review; MT: Regular Issue; RC254-282; microRNAs; circular RNAs

The cell cycle comprises sequential events during which a cell duplicates its genome and divides it into two daughter cells. This process is tightly regulated to ensure that the daughter cell receives identical copied chromosomal DNA and that any errors in the DNA during replication are correctly repaired. Cyclins and their enzyme partners, cyclin-dependent kinases (CDKs), are critical regulators of G- to M-phase transitions during the cell cycle. Mitogenic signals induce the formation of the cyclin/CDK complexes, resulting in phosphorylation and activation of the CDKs. Once activated, cyclin/CDK complexes phosphorylate specific substrates that drive the cell cycle forward. The sequential activation and inactivation of cyclin-CDK complexes are tightly controlled by activating and inactivating phosphorylation events induced by cell-cycle proteins. The non-coding RNAs (ncRNAs), which do not code for proteins, regulate cell-cycle proteins at the transcriptional and translational levels, thereby controlling their expression at different cell-cycle phases. Deregulation of ncRNAs can cause abnormal expression patterns of cell-cycle-regulating proteins, resulting in abnormalities in cell-cycle regulation and cancer development. This review explores how ncRNA dysregulation can disrupt cell division balance and discusses potential therapeutic approaches targeting these ncRNAs to control cell-cycle events in cancer treatment.